Utilization and determinants of use of non-pharmacological interventions in COPD: Results of the COSYCONET cohort

Lutter, Johanna I.; Lukas, Marco; Schwarzkopf, Larissa; Jörres, Rudolf A.; Studnicka, Michael; Kahnert, Kathrin; Karrasch, Stefan; Bewig, Burkhard; Vogelmeier, Claus; Holle, Rolf

doi:10.1016/j.rmed.2020.106087

Cited by 12 publications

(7 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In Germany, only 24% of patients with COPD who were current/former smokers had participated in smoking cessation counselling. 25 …”

Section: Resultsmentioning

confidence: 99%

Qualitative Validation of COPD Evidenced Care Pathways in Japan, Canada, England, and Germany: Common Barriers to Optimal COPD Care

Meiwald¹,

Gara-Adams²,

Rowlandson³

et al. 2022

COPD

View full text Add to dashboard Cite

Background Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide. A comprehensive and detailed understanding of COPD care pathways from pre-diagnosis to acute care is required to understand the common barriers to optimal COPD care across diverse health systems. Methods Country-specific COPD care pathways were created for four high-income countries using international recommendations and country-specific guidelines, then populated with published epidemiological, clinical, and economic data. To refine and validate the pathways, semi-structured interviews using pre-prepared discussion guides and country-specific pathway maps were held with twenty-four primary and secondary care respiratory healthcare professionals. Thematic analysis was then performed on the interview transcripts. Results The COPD care pathway showed broad consistency across the countries. Three key themes relating to barriers in optimal COPD management were identified across the countries: journey to diagnosis, treatment, and the impact of COVID-19. Common barriers included presentation to healthcare with advanced COPD, low COPD consideration, and sub-optimal acute and chronic disease management. COVID-19 has negatively impacted disease management across the pathway but presents opportunities to retain virtual consultations. Structural factors such as insurance and short duration of appointments also impacted the diagnosis and management of COPD. Conclusion COPD is an important public health issue that needs urgent prioritization. The use of Evidenced Care Pathways with decision-makers can facilitate evidence-based decision making on interventions and policies to improve care and outcomes for patients and reduce unnecessary resource use and associated costs for the healthcare provider/payer.

show abstract

“…In Germany, only 24% of patients with COPD who were current/former smokers had participated in smoking cessation counselling. 25 …”

Section: Resultsmentioning

confidence: 99%

Qualitative Validation of COPD Evidenced Care Pathways in Japan, Canada, England, and Germany: Common Barriers to Optimal COPD Care

Meiwald¹,

Gara-Adams²,

Rowlandson³

et al. 2022

COPD

View full text Add to dashboard Cite

show abstract

“… 16 In Germany only 34% of COPD patients reported ever having participated in an outpatient or inpatient PR programme. 51 Patients that were older, female, more deprived, or had a comorbidity of diabetes, asthma, or painful condition had significantly lower odds of referral to PR. 52 …”

Section: Management Of Stable Diseasementioning

confidence: 95%

“… 59 Participation rates were higher overall in Germany (40%) but again participation was higher in women than in men (43% vs 35%). 51 In the UK only 32% of patients reported having a self-management plan and only 60% of patients with a plan reported that they had been involved in its creation. 22 In a separate analysis of self-reported data from diagnosed COPD patients in Birmingham only 40% had self-management plans and 50% reported never having received advice on diet or exercise.…”

Section: Management Of Stable Diseasementioning

confidence: 99%

Clinical Management of COPD in the Real World: Can Studies Reveal Errors in Management and Pathways to Improve Patient Care?

Halpin¹

2023

POR

View full text Add to dashboard Cite

Real world data comprise information on health care that is derived from multiple sources outside typical clinical research settings. This review focuses on what real world evidence tells us about problems with the diagnosis of chronic obstructive pulmonary disease (COPD), problems with the initial and follow-up pharmacological and non-pharmacological management, problems with the management of exacerbations and problems with palliative care. Data from real world studies show errors in the management of COPD with delays to diagnosis, lack of confirmation of the diagnosis with spirometry, lack of holistic assessment, lack of attention to smoking cessation, variable adherence to management guidelines, delayed implementation of appropriate interventions, under-recognition of patients at higher risk of adverse outcomes, high hospitalisation rates for exacerbations and poor implementation of palliative care. Understanding that these problems exist and considering how and why they occur is fundamental to developing solutions to improve the diagnosis and management of patients with COPD.

show abstract

“…[30] Nonpharmacological interventions for COPD patients generally include preventive measures, such as smoking cessation and vaccination, pulmonary rehabilitation (i.e., physical activity and self-management), oxygen therapy, and surgical interventions. [32][33][34][35][36][37] While understanding of the importance of non-pharmacological interventions as a component of COPD therapy has evolved rapidly, knowledge regarding their effectiveness is lacking among COPD patients, whose judgment is largely based on their perceptions and experiences.…”

Section: The Authors Have No Conflicts Of Interest To Disclosementioning

confidence: 99%

Perceptions of the effectiveness of non-pharmacological management of respiratory disorders among CRD patients

Aldabayan

2023

Medicine

View full text Add to dashboard Cite

Chronic respiratory diseases (CRDs) are among the leading cause of mortality worldwide. While pharmacological approaches are commonly used to manage symptoms, non-pharmacological management of CRDs is considered crucial in preventing disease progression and improving patient self-efficacy. To describe the perceived effectiveness of non-pharmacological management of CRDs among CRD patients and determine whether the CRD patients perceptions of the effectiveness of non-pharmacological management are associated with their demographic characteristics. An analytic cross-sectional study design was utilized. The non-pharmacological management practices of CRD patients and their perception of the effectiveness of these therapeutic measures were assessed using a researcher-developed questionnaire. Data collection took place in primary healthcare centers in Al Ahsa, Saudi Arabia from October 2021 to March 2022. The proportion of CRD patients who perceived that non-pharmacological interventions were effective was computed. Binary logistic regression was performed to determine the association between the demographic characteristics of the respondents and their perception of the effectiveness of non-pharmacological management. Among the 390 respondents, 42% perceived that non-pharmacological measures were effective. Half of the respondents believed that smoking cessation, influenza vaccination, improving physical activity, and nutrition support helped alleviate CRD symptoms, while less than half of the respondents considered pulmonary rehabilitation, educational programs, and oxygen therapy effective measures to control symptoms. Women were found to be 3.24 times more likely to perceive non-pharmacological interventions as effective (P < .0000) compared to men. Those with university-level education were 66.6% less likely to consider non-pharmacological interventions to be effective (P < .0000) than those who completed preuniversity-level education. Age and marital status did not significantly influence perceptions of effectiveness. Differences in the perceptions of the effectiveness of various non-pharmacological measures to alleviate CRD symptoms existed among the CRD patients of Al Ahsa. The perception of effectiveness was significantly associated with the patient’s gender and educational attainment.

show abstract

Utilization and determinants of use of non-pharmacological interventions in COPD: Results of the COSYCONET cohort

Cited by 12 publications

References 36 publications

Qualitative Validation of COPD Evidenced Care Pathways in Japan, Canada, England, and Germany: Common Barriers to Optimal COPD Care

Qualitative Validation of COPD Evidenced Care Pathways in Japan, Canada, England, and Germany: Common Barriers to Optimal COPD Care

Clinical Management of COPD in the Real World: Can Studies Reveal Errors in Management and Pathways to Improve Patient Care?

Perceptions of the effectiveness of non-pharmacological management of respiratory disorders among CRD patients

Contact Info

Product

Resources

About